There are reports of increased frequency of endometrial cancer in MSH6 mutation carriers versus MSH2 mutation carriers [8]; however, two large studies found no difference [2] or even a decreased [3] endometrial cancer incidence in patients carrying a mutation in MSH6. This evidence concerns the gene MSH2 and endometrial cancer.